These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The use of Limulus testing to reduce the incidence of adverse reactions to cisternographic agents. Rhodes BA; Kamanetz GS; Wagner HN Neurology; 1974 Sep; 24(9):810-2. PubMed ID: 4859558 [No Abstract] [Full Text] [Related]
5. [RI cisternography with 111-In-DTPA]. Tokuriki Y; Miwa Y; Murata T; Fukumitsu T; Matsumura T No To Shinkei; 1976 Jun; 28(6):579-88. PubMed ID: 1036152 [TBL] [Abstract][Full Text] [Related]
6. Endotoxin as a cause of aseptic meningitis after radionuclide cisternography. Cooper JF; Harbert JC J Nucl Med; 1975 Sep; 16(9):809-13. PubMed ID: 1174137 [TBL] [Abstract][Full Text] [Related]
7. Dosimetry of several DTPA radiopharmaceuticals in cisternography. Brookeman VA; Morin RL J Nucl Med; 1975 Dec; 16(12):1177-82. PubMed ID: 1242727 [TBL] [Abstract][Full Text] [Related]
8. Comparison between 131I-IHSA and 169Yb-DTPA for cisternography. Harbert JC; Reed V; McCullough DC J Nucl Med; 1973 Oct; 14(10):765-8. PubMed ID: 4743586 [No Abstract] [Full Text] [Related]
9. Stasis of 111In-DTPA in the posterior fossa in patients with cerebellar degeneration. Lusins J J Nucl Med; 1976 May; 17(5):349-51. PubMed ID: 1262935 [TBL] [Abstract][Full Text] [Related]
11. Use of serial cisternograms to document dynamic changes in the development of communicating hydrocephalus: a clinical and experimental study. James AE; Sperber E; Strecker EP; Digel C; Novak G; Bush M Acta Neurol Scand; 1974; 50(2):153-70. PubMed ID: 4835618 [No Abstract] [Full Text] [Related]